Xiaoyang Xu

Xiaoyang Xu

Auto-generated profile, based on publicly available information

Xiaoyang Xu

New Jersey Institute of Technology

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Trends in Molecular Medicine
Verified
Journal Article
Open access
XXXiaoyang Xu
Xiaoyang Xu
WHWilliam Ho
William Ho
XZXueqing Zhang
Xueqing Zhang
NBNicolas Bertrand
Nicolas Bertrand
OFOmid Farokhzad
Omid Farokhzad
The advent of nanomedicine marks an unparalleled opportunity to advance the treatment of various diseases, including cancer. The unique properties of nanoparticles (NPs), such as large surface-to-volume ratio, small size, the ability to encapsulate various drugs, and tunable surface chemistry, give them many advantages over their bulk counterparts. This includes multivalent surface modification with targeting ligands, efficient navigation of the complex in vivo environment, increased intracellular trafficking, and sustained release of drug payload. These advantages make NPs a mode of treatment potentially superior to conventional cancer therapies. This review highlights the most recent developments in cancer treatment using NPs as drug delivery vehicles, including promising opportunities in targeted and combination therapy.

1 December 2018 in Bioactive Materials
Verified
Journal Article
Open access
XBXin Bai
Xin Bai
MGMingzhu Gao
Mingzhu Gao
SSSahla Syed
Sahla Syed
JZJerry Zhuang
Jerry Zhuang
XXXiaoyang Xu
Xiaoyang Xu
XZXue-Qing Zhang
Xue-Qing Zhang
Bone self-healing is limited and generally requires external intervention to augment bone repair and regeneration. While traditional methods for repairing bone defects such as autografts, allografts, and xenografts have been widely used, they all have corresponding disadvantages, thus limiting their clinical use. Despite the development of a variety of biomaterials, including metal implants, calcium phosphate cements (CPC), hydroxyapatite, etc., the desired therapeutic effect is not fully achieved. Currently, polymeric scaffolds, particularly hydrogels, are of interest and their unique configurations and tunable physicochemical properties have been extensively studied. This review will focus on the applications of various cutting-edge bioactive hydrogels systems in bone regeneration, as well as their advantages and limitations. We will examine the composition and defects of the bone, discuss the current biomaterials for bone regeneration, and classify recently developed polymeric materials for hydrogel synthesis. We will also elaborate on the properties of desirable hydrogels as well as the fabrication techniques and different delivery strategies. Finally, the existing challenges, considerations, and the future prospective of hydrogels in bone regeneration will be outlined.

1 September 2016 in Bioactive Materials
Verified
Journal Article
Open access
YTYung-Hao Tsou
Yung-Hao Tsou
JKJoe Khoneisser
Joe Khoneisser
PHPing-Chun Huang
Ping-Chun Huang
XXXiaoyang Xu
Xiaoyang Xu
The encapsulation of stem cells in a hydrogel substrate provides a promising future in biomedical applications. However, communications between hydrogels and stem cells is complicated; various factors such as porosity, different polymer types, stiffness, compatibility and degradation will lead to stem cell survival or death. Hydrogels mimic the three-dimensional extracellular matrix to provide a friendly environment for stem cells. On the other hand, stem cells can sense the surroundings to make the next progression, stretching out, proliferating or just to remain. As such, understanding the correlation between stem cells and hydrogels is crucial. In this Review, we first discuss the varying types of the hydrogels and stem cells, which are most commonly used in the biomedical fields and further investigate how hydrogels interact with stem cells from the perspective of their biomedical application, while providing insights into the design and development of hydrogels for drug delivery, tissue engineering and regenerative medicine purpose. In addition, we compare the results such as stiffness, degradation time and pore size as well as peptide types of hydrogels from respected journals. We also discussed most recently magnificent materials and their effects to regulate stem cell fate.

18 January 2021 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
WHWilliam Ho
William Ho
MGMingzhu Gao
Mingzhu Gao
FLFengqiao Li
Fengqiao Li
ZLZhongyu Li
Zhongyu Li
XZXue‐Qing Zhang
Xue‐Qing Zhang
XXXiaoyang Xu
Xiaoyang Xu

16 October 2017 in Small
Verified
Journal Article
Closed access
PDF file
YTYung‐Hao Tsou
Yung‐Hao Tsou
XZXue‐Qing Zhang
Xue‐Qing Zhang
HZHe Zhu
He Zhu
SSSahla Syed
Sahla Syed
XXXiaoyang Xu
Xiaoyang Xu

1 December 2021 in Bioactive Materials
Verified
Journal Article
Open access
BHBin Hu
Bin Hu
MGMingzhu Gao
Mingzhu Gao
KBKofi Oti Boakye-Yiadom
Kofi Oti Boakye-Yiadom
WHWilliam Ho
William Ho
WYWei Yu
Wei Yu
XZXue-Qing Zhang
Xue-Qing Zhang
Prolonged, intense inflammation and excessive oxidative stress hinder diabetic wounds from healing normally, leading to disorders downstream including the postponement of re-epithelialization and extracellular matrix (ECM) formation. Herein, we report a hyaluronic acid (HA) and chitosan based hydrogel (OHA-CMC) with inherent antibacterial and hemostatic activities fabricated via Schiff base reaction. By encapsulating nanotechnologically-modified curcumin (CNP) and epidermal growth factor (EGF) into the hydrogel, OHA-CMC/CNP/EGF exhibited extraordinary antioxidant, anti-inflammatory, and migration-promoting effects in vitro. Meanwhile, OHA-CMC/CNP/EGF presented on-demand drug release in synchrony with the phases of the wound healing process. Specifically, curcumin was rapidly and constantly released to alleviate inflammation and oxidative stress in the early phase of wound healing, while a more gradual and sustained release of EGF supported late proliferation and ECM remodeling. In a diabetic full-thickness skin defect model, OHA-CMC/CNP/EGF dramatically improved wound healing with ideal re-epithelialization, granulation tissue formation, and skin appendage regeneration, highlighting the enormous therapeutic potential this biomaterial holds as a diabetic wound dressing.